Patents by Inventor Grahame Robert Woollam

Grahame Robert Woollam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds
    Patent number: 8178573
    Abstract: The present invention provides compounds of formula (I): pharmaceutical compositions comprising the compounds and the use of the compounds for the manufacture of a medicament, particularly for the treatment of inflammation and/or allergic conditions.
    Type: Grant
    Filed: April 18, 2007
    Date of Patent: May 15, 2012
    Assignee: Glaxo Group Limited
    Inventors: Keith Biggadike, Anthony William James Cooper, David House, Iain McFarlane McLay, Grahame Robert Woollam
  • HEMI-FUMARATE SALT OF A 1,3,4-THIADIAZOLYL DERIVATIVE AS MODULATOR OF THE SPHINGOSINE 1-PHOSPHATE RECEPTOR
    Publication number: 20110034524
    Abstract: The invention relates to the compound (2S)-2-amino-2-{5-[4-(octyloxy)-3-(trifluoromethyl)phenyl]-1,3,4-thiadiazol-2-yl}-1-propanol hemi-fumarate, processes for its preparation, pharmaceutical compositions containing them and its use in the treatment of conditions or disorders which are mediated via the S1P1 receptor.
    Type: Application
    Filed: February 3, 2009
    Publication date: February 10, 2011
    Applicant: Glaxo Group Limited
    Inventors: Michael Simon Anson, Caroline Jane Day, Jonathan Paul Graham, Leanda Jane Kindon, Grahame Robert Woollam
  • Monomaleate Monohydrate Salt of a 5HT1A Receptor Antagonist
    Publication number: 20100317672
    Abstract: The present invention relates to a monomaleate monohydrate salt of 7-methyl-6-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}-4,5-dihydroimidazo[1,5-a]quinoline-3-carboxamide, uses of the salt as a medicament in the treatment of sexual dysfunction and pharmaceutical compositions and dosage forms comprising the salt.
    Type: Application
    Filed: January 15, 2009
    Publication date: December 16, 2010
    Applicant: GLAXO GROUP LIMITED
    Inventors: Clare Louise Anderton, Grahame Robert Woollam
  • Novel Compounds
    Publication number: 20090111866
    Abstract: The present invention provides compounds of formula (I): pharmaceutical compositions comprising the compounds and the use of the compounds for the manufacture of a medicament, particularly for the treatment of inflammation and/or allergic conditions.
    Type: Application
    Filed: April 18, 2007
    Publication date: April 30, 2009
    Applicant: Glaxo Wellcome House
    Inventors: Keith Biggadike, Anthony William James Cooper, David House, Iain McFarlane McLay, Grahame Robert Woollam